|
WO2020157338A1
|
|
Refractive wavefront correction device
|
|
WO2020157274A1
|
|
Methods for optimizing heterologous gene expression
|
|
DE102019203155A1
|
|
System for predicting at least one cardiac dysfunction in an individual
|
|
WO2016207436A1
|
|
Branched proximity hybridization assay
|
|
EP3260133A1
|
|
Antibodies against mac-1
|
|
WO2016162398A1
|
|
Apparatus for detecting electronic faults on silicon-based semiconductor wafers
|
|
WO2016162406A1
|
|
Device for detecting electronic defects in the edge region of silicon-based semiconductors
|
|
DE102016204683B3
|
|
METHOD FOR THE AUTOMATIC FREQUENCY ADAPTATION OF FILTERS DURING OPERATION IN CLOSED CONTROL GRINDING
|
|
EP3265504A1
|
|
Ionic-liquid mediated production of cellulose nanocrystals directly from wood, grass or bioresidues
|
|
DE102016103597A1
|
|
Implantable cuff electrode
|
|
DE102016102594A1
|
|
Process for the preparation of doped graphene oxide and / or graphene
|
|
DE102016201181B3
|
|
Tube with a microfluidic structure
|
|
DE102016200981A1
|
|
Optical implant and method for irradiating an object with light
|
|
EP3196295A1
|
|
Method of producing renal cells from fibroblasts
|
|
EP3178809A1
|
|
Hybrid molecule with structural and activity elements of resveratrol and diallyl sulfide
|
|
DE102015223541A1
|
|
Implantable fluid pump system
|
|
DE102015119360A1
|
|
Method and device for testing the contacting quality of an electrical contact between a solar cell and a contacting unit
|
|
EP3165224A1
|
|
Use of pde4 inhibitors for the prophylaxis and/or therapy of dyslipoproteinaemia and related disorders
|
|
DE102015219458A1
|
|
CIRCUIT ARRANGEMENT AND METHOD FOR THE DIGITAL CORRECTION OF MODULATION EFFECTS IN ELECTROMECHANICAL DELTA-SIGMA MODULATORS
|
|
DE102015216841A1
|
|
Device and method for the optical stimulation of an optically activatable biological sample
|
